Effect of BIBW 2948 BS in COPD

NCT00423137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive
Bronchitis, Chronic

Interventions

DRUG: BIBW 2948 BS
DRUG: Placebo

Sponsor

Boehringer Ingelheim